Pharma & Healthcare Market Research Report

Report Filter Reset All

Sort By Price

Published Date

Category

Clear All

Publishers

Clear All

Report Type

Continents

Clear All

Regions

Clear All

Countries

Clear All

Pharma & Healthcare

Global (United States, European Union and China) Gummy Vitamins Market Research Report 2019-2025

Gummy vitamins are better tasting and easier-to-swallow than multivitamin tablets, but this convenience comes at a significant cost. In 2019, the market size...

$3,280.00 09 August, 2019 | QYResearch

Gummy vitamins are better tasting and easier-to-swallow than multivitamin tablets, but this convenience comes at a significant cost. In 2019, the m...

Pharma & Healthcare

Global (United States, European Union and China) Hyperphosphatemia Drugs Market Research Report 2019-2025

hosphorus is an important element for normal physiologic functions such as bone construction, nerve function, and muscle contraction. About 85% of phosphorus...

$3,280.00 09 August, 2019 | QYResearch

hosphorus is an important element for normal physiologic functions such as bone construction, nerve function, and muscle contraction. About 85% of ...

Pharma & Healthcare

Global (United States, European Union and China) Jet Lag Treatment Market Research Report 2019-2025

Jet lag treatment has complicated and expensive treatment procedure. Patients get medications from the hospital pharmacies, retail pharmacies, online sales, ...

$3,280.00 09 August, 2019 | QYResearch

Jet lag treatment has complicated and expensive treatment procedure. Patients get medications from the hospital pharmacies, retail pharmacies, onli...

Pharma & Healthcare

Global (United States, European Union and China) Esmolol Hydrochloride Market Research Report 2019-2025

Esmolol is a class II antiarrhythmic drug used to prevent and treat tachycardia and acute supraventricular tachycardia. Esmolol hydrochlorlde injection is us...

$3,280.00 09 August, 2019 | QYResearch

Esmolol is a class II antiarrhythmic drug used to prevent and treat tachycardia and acute supraventricular tachycardia. Esmolol hydrochlorlde injec...

Pharma & Healthcare

Global (United States, European Union and China) Live Attenuated Vaccines Market Research Report 2019-2025

An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious ...

$3,280.00 09 August, 2019 | QYResearch

An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an i...

Pharma & Healthcare

Global (United States, European Union and China) Aerrane Market Research Report 2019-2025

Aerrane(Isoflurane), sold under the trade name Forane among others, is a general anesthetic. It can be used to start or maintain anesthesia. In 2019, the ma...

$3,280.00 09 August, 2019 | QYResearch

Aerrane(Isoflurane), sold under the trade name Forane among others, is a general anesthetic. It can be used to start or maintain anesthesia. In 20...

Pharma & Healthcare

Global (United States, European Union and China) Animal Biotechnology Market Research Report 2019-2025

Animal biotechnology refers to the branch of biotechnology, which deals with the molecular biology techniques for producing genetically engineered animals (w...

$3,280.00 09 August, 2019 | QYResearch

Animal biotechnology refers to the branch of biotechnology, which deals with the molecular biology techniques for producing genetically engineered ...

Pharma & Healthcare

Global (United States, European Union and China) Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Research Report 2019-2025

DTaP (also DTPa and TDaP) is a combined vaccine against diphtheria, tetanus, and pertussis, in which the pertussis component is acellular. This is in contras...

$3,280.00 09 August, 2019 | QYResearch

DTaP (also DTPa and TDaP) is a combined vaccine against diphtheria, tetanus, and pertussis, in which the pertussis component is acellular. This is ...

Pharma & Healthcare

Global Glimepiride Market Insights, Forecast to 2025

Glimepiride is a member of the second-generation sulfonylurea (SU) drug class used for the management of type 2 diabetes mellitus (T2DM) to improve glycemic ...

$3,900.00 13 August, 2019 | QYResearch

Global Glimepiride Market Insights, Forecast to 2025

$3,900.00 | 13 August, 2019 | QYResearch

Glimepiride is a member of the second-generation sulfonylurea (SU) drug class used for the management of type 2 diabetes mellitus (T2DM) to improve...

Pharma & Healthcare

Global (United States, European Union and China) Medication Management System Market Research Report 2019-2025

Medication management systems ensure tracking and validation of the medication administered to patients at all points of care. These systems help healthcare ...

$3,280.00 13 August, 2019 | QYResearch

Medication management systems ensure tracking and validation of the medication administered to patients at all points of care. These systems help h...